Oncology Biomarker Diagnostics

Linking molecular status to breakthroughs in cancer treatment

Board of Directors

Sheridan Snyder, LLB (Hon) - Chairman

Chad Galderisi, D.O. - Vice President of Medical Affairs, MolecularMD

Frederick “Fritz” Eibel, Head of Commercial Operations, Genetic Analysis Division, Sequenom

Matt Rice, MBA - Principal, Ballast Point Ventures

Peter Maag, Ph.D. - President and Chief Executive Officer, XDx, Inc.

Dan Snyder, MBA - President and Chief Executive Officer, MolecularMD

Oncology Thought Leaders Series:
Brian Druker, MD speaks on the value of
companion diagnostics in patient outcomes